Immunoglobulin a multiple myeloma with cutaneous involvement in a dog

Canadian Veterinary Journal

Volumn 49, Issue 7, 2008, Pages 694-702

  Mayer, Monique N ^a   Kerr, Moira E ^a   Grier, Candace K ^a   MacDonald, Valerie S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DOG; DOG DISEASE; FATALITY; IMMUNOLOGY; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; PROTEINURIA; SKIN TUMOR;

ANIMALS; COMBINED MODALITY THERAPY; DOG DISEASES; DOGS; FATAL OUTCOME; IMMUNOGLOBULIN A; MALE; MULTIPLE MYELOMA; PROTEINURIA; SKIN NEOPLASMS;

CANIS FAMILIARIS;

EID: 49349098968     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tizard IR. Veterinary Immunology: An Introduction, 6th ed. Philadelphia: WB Saunders, 2000:139-148.
2. Platz SJ, Breuer W, Pfleghaar S, Minkus G, Hermanns W. Prognostic value of histopathological grading in canine extramedullary plasmacytomas. Vet Pathol 1999;36:23-27.
3. Thrall MA. Lymphoproliferative disorders. Lymphocytic leukemia and plasma cell myeloma. Vet Clin North Am Small Anim Pract 1981;11: 321-347.
4. Fry MM, McGavin MD. Bone marrow, blood cells, and lymphatic system. In: McGavin MD, Zachary JF, eds. Pathologic Basis of Veterinary Disease. 4th ed. St. Louis: Mosby Elsevier, 2007:743-832.
5. Nolan KD, Mone MC, Nelson EW. Plasma cell neoplasms. Review of disease progression and report of a new variant. Surg Oncol 2005; 14:85-90.
6. Vail DM. Hematopoietic tumors section D plasma cell neoplasms. In: Withrow SJ, Vail DM, eds. Small Animal Clinical Oncology. 4th ed. St. Louis: Saunders Elsevier, 2007:769-784.
7. Walton GS, Gopinath C. Multiple myeloma in a dog with some unusual features. J Small Anim Pract 1972;13:703-708.
8. Munshi NC, Anderson KC. Plasma cell neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005: 2155-2188.
9. Jacobs RM, Messick JB, Valli VE. Tumors of the hemolymphatic system. In: Meuten DJ, ed. Tumors in Domestic Animals. 4th ed. Iowa: Iowa State Univers Pr, 2002:119-198.
10. Clark AD, Shetty A, Soutar R. Renal failure and multiple myeloma: Pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Rev 1999;13:79-90.
11. Preston FE. Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia. J Clin Pathol Suppl (R Coll Pathol) 1979;13:85-89.
12. MacEwen EG, Hurvitz AI. Diagnosis and management of monoclonal gammopathies. Vet Clin North Am 1977;7:119-132.
13. Kyle KA, Child JA, Anderson K, et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 2003;121:749-757.
14. Bartl R, Frisch B, Diem H, Mundel M, Fateh-Moghadam A. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma - a new prognostic strategy. Eur J Haematol Suppl 1989;51:88-98.
15. Haines DM, Chelack BJ. Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. J Vet Diagn Invest 1991;3:101-112.
16. Matus RE, Leifer CE. Immunoglobulin-producing tumors. Vet Clin North Am Small Anim Pract 1985;15:741-753.
17. Eby C, Blinder M. Hemostatic complications associated with paraproteinemias. Curr Hematol Rep 2003;2:388-394.
18. Osborne CA, Perman V, Sautter JH, Stevens JB, Hanlon GF. Multiple myeloma in the dog. J Am Vet Med Assoc 1968;153:1300-1319.
19. Matus RE, Leifer CE, MacEwen EG, Hurvitz AI. Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 1986; 188:1288-1292.
20. Giraudel JM, Pages JP, Guelfi JF. Monoclonal gammopathies in the dog: A retrospective study of 18 cases (1986-1999) and literature review. J Am Anim Hosp Assoc 2002;38:135-147.
21. Boone LI. Bence-Jones proteins. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. 5th ed. Baltimore: Lippincott Williams & Wilkins, 2000:925-928.
22. Schellenberg S, Gentilini F, Claus TM, Reusch CE. The effect of hydrocortisone on urinary protein excretion in dogs [abstract]. Research Abstract Program of the 24th Annu ACVIM Forum, Louisville, Kentucky, May 31 - June 3, 2006. J Vet Intern Med 2006;20:741.
23. MacNamara EM, Aguzzi F, Petrini C, et al. Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: A cause for confusion with Bence Jones protein. Clin Chem 1991;37:1570-1574.
24. Leigh BR, Kurtts TA, Mack CF, Matzner MB, Shimm DS. Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys 1993;25:801-804.
25. Rowell NP, Tobias JS. The role of radiotherapy in the management of multiple myeloma. Blood Rev 1991;5:84-89.
26. Bosch A, Frias Z. Radiotherapy in the treatment of multiple myeloma. Int J Radiat Oncol Biol Phys 1988;15:1363-1369.
27. Adamietz IA, Schober C, Schulte RW, Peest D, Renner K. Palliative radiotherapy in plasma cell myeloma. Radiother Oncol 1991;20:111-116.
28. Terpos E, Dimopoulos MA. Myeloma bone disease: Pathophysiology and management. Ann Oncol 2005;16:1223-1231.
29. Singer CR, Tobias JS, Giles F, Rudd GN, Blackman GM, Richards JD. Hemibody irradiation. An effective second-line therapy in drug-resistance multiple myeloma. Cancer 1989;63:2446-2451.
30. MacEwen EG, Patnaik AK, Hurvitz AI, et al. Nonsecretory multiple myeloma in two dogs. J Am Vet Med Assoc 1984;184:1283-1286.
31. Cowgill ES, Neel JA, Ruslander D. Light-chain myeloma in a dog. J Vet Intern Med 2004;18:119-121.
32. Requena L, Kutzner H, Palmedo G, et al. Cutaneous involvement in multiple myeloma: A clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases. Arch Dermatol 2003;139:475-486.